Bezafibrate has Powerful Hypolipidaemic Effects

Gespeichert in:

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	1989

Schlagwörter:	Carbohydrate Metabolism Bezafibrate Peripheral Insulin Sensitivity VLDL Cholesterol VLDL Triglyceride

Anmerkung:	© Adis International Ltd 1989

Übergeordnetes Werk:	Enthalten in: Inpharma weekly - Auckland : ADIS internat., 1975, 675(1989), 1 vom: Feb., Seite 16-16
Übergeordnetes Werk:	volume:675 ; year:1989 ; number:1 ; month:02 ; pages:16-16

Links:	Volltext

DOI / URN:	10.1007/BF03296402

Katalog-ID:	SPR035973447

Internformat


LEADER	01000caa a22002652 4500
001	SPR035973447
003	DE-627
005	20230519123207.0
007	cr uuu---uuuuu
008	201007s1989 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1007/BF03296402 \|2 doi
035			\|a (DE-627)SPR035973447
035			\|a (SPR)BF03296402-e
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a Bezafibrate has Powerful Hypolipidaemic Effects
264		1	\|c 1989
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a © Adis International Ltd 1989
650		4	\|a Carbohydrate Metabolism \|7 (dpeaa)DE-He213
650		4	\|a Bezafibrate \|7 (dpeaa)DE-He213
650		4	\|a Peripheral Insulin Sensitivity \|7 (dpeaa)DE-He213
650		4	\|a VLDL Cholesterol \|7 (dpeaa)DE-He213
650		4	\|a VLDL Triglyceride \|7 (dpeaa)DE-He213
773	0	8	\|i Enthalten in \|t Inpharma weekly \|d Auckland : ADIS internat., 1975 \|g 675(1989), 1 vom: Feb., Seite 16-16 \|w (DE-627)373977859 \|w (DE-600)2127607-9 \|x 2230-6056 \|7 nnns
773	1	8	\|g volume:675 \|g year:1989 \|g number:1 \|g month:02 \|g pages:16-16
856	4	0	\|u https://dx.doi.org/10.1007/BF03296402 \|z lizenzpflichtig \|3 Volltext
912			\|a GBV_USEFLAG_A
912			\|a SYSFLAG_A
912			\|a GBV_SPRINGER
912			\|a SSG-OLC-PHA
912			\|a GBV_ILN_20
951			\|a AR
952			\|d 675 \|j 1989 \|e 1 \|c 02 \|h 16-16

Indexfelder

matchkey_str	article:22306056:1989----::eairthsoeflyoii
hierarchy_sort_str	1989
publishDate	1989
allfields	10.1007/BF03296402 doi (DE-627)SPR035973447 (SPR)BF03296402-e DE-627 ger DE-627 rakwb eng Bezafibrate has Powerful Hypolipidaemic Effects 1989 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1989 Carbohydrate Metabolism (dpeaa)DE-He213 Bezafibrate (dpeaa)DE-He213 Peripheral Insulin Sensitivity (dpeaa)DE-He213 VLDL Cholesterol (dpeaa)DE-He213 VLDL Triglyceride (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 675(1989), 1 vom: Feb., Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:675 year:1989 number:1 month:02 pages:16-16 https://dx.doi.org/10.1007/BF03296402 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 675 1989 1 02 16-16
spelling	10.1007/BF03296402 doi (DE-627)SPR035973447 (SPR)BF03296402-e DE-627 ger DE-627 rakwb eng Bezafibrate has Powerful Hypolipidaemic Effects 1989 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1989 Carbohydrate Metabolism (dpeaa)DE-He213 Bezafibrate (dpeaa)DE-He213 Peripheral Insulin Sensitivity (dpeaa)DE-He213 VLDL Cholesterol (dpeaa)DE-He213 VLDL Triglyceride (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 675(1989), 1 vom: Feb., Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:675 year:1989 number:1 month:02 pages:16-16 https://dx.doi.org/10.1007/BF03296402 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 675 1989 1 02 16-16
allfields_unstemmed	10.1007/BF03296402 doi (DE-627)SPR035973447 (SPR)BF03296402-e DE-627 ger DE-627 rakwb eng Bezafibrate has Powerful Hypolipidaemic Effects 1989 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1989 Carbohydrate Metabolism (dpeaa)DE-He213 Bezafibrate (dpeaa)DE-He213 Peripheral Insulin Sensitivity (dpeaa)DE-He213 VLDL Cholesterol (dpeaa)DE-He213 VLDL Triglyceride (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 675(1989), 1 vom: Feb., Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:675 year:1989 number:1 month:02 pages:16-16 https://dx.doi.org/10.1007/BF03296402 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 675 1989 1 02 16-16
allfieldsGer	10.1007/BF03296402 doi (DE-627)SPR035973447 (SPR)BF03296402-e DE-627 ger DE-627 rakwb eng Bezafibrate has Powerful Hypolipidaemic Effects 1989 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1989 Carbohydrate Metabolism (dpeaa)DE-He213 Bezafibrate (dpeaa)DE-He213 Peripheral Insulin Sensitivity (dpeaa)DE-He213 VLDL Cholesterol (dpeaa)DE-He213 VLDL Triglyceride (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 675(1989), 1 vom: Feb., Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:675 year:1989 number:1 month:02 pages:16-16 https://dx.doi.org/10.1007/BF03296402 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 675 1989 1 02 16-16
allfieldsSound	10.1007/BF03296402 doi (DE-627)SPR035973447 (SPR)BF03296402-e DE-627 ger DE-627 rakwb eng Bezafibrate has Powerful Hypolipidaemic Effects 1989 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier © Adis International Ltd 1989 Carbohydrate Metabolism (dpeaa)DE-He213 Bezafibrate (dpeaa)DE-He213 Peripheral Insulin Sensitivity (dpeaa)DE-He213 VLDL Cholesterol (dpeaa)DE-He213 VLDL Triglyceride (dpeaa)DE-He213 Enthalten in Inpharma weekly Auckland : ADIS internat., 1975 675(1989), 1 vom: Feb., Seite 16-16 (DE-627)373977859 (DE-600)2127607-9 2230-6056 nnns volume:675 year:1989 number:1 month:02 pages:16-16 https://dx.doi.org/10.1007/BF03296402 lizenzpflichtig Volltext GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20 AR 675 1989 1 02 16-16
language	English
source	Enthalten in Inpharma weekly 675(1989), 1 vom: Feb., Seite 16-16 volume:675 year:1989 number:1 month:02 pages:16-16
sourceStr	Enthalten in Inpharma weekly 675(1989), 1 vom: Feb., Seite 16-16 volume:675 year:1989 number:1 month:02 pages:16-16
format_phy_str_mv	Article
institution	findex.gbv.de
topic_facet	Carbohydrate Metabolism Bezafibrate Peripheral Insulin Sensitivity VLDL Cholesterol VLDL Triglyceride
isfreeaccess_bool	false
container_title	Inpharma weekly
publishDateDaySort_date	1989-02-01T00:00:00Z
hierarchy_top_id	373977859
id	SPR035973447
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035973447</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519123207.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1989 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/BF03296402</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035973447</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)BF03296402-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bezafibrate has Powerful Hypolipidaemic Effects</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1989</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1989</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carbohydrate Metabolism</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bezafibrate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Peripheral Insulin Sensitivity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">VLDL Cholesterol</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">VLDL Triglyceride</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">675(1989), 1 vom: Feb., Seite 16-16</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:675</subfield><subfield code="g">year:1989</subfield><subfield code="g">number:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:16-16</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/BF03296402</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">675</subfield><subfield code="j">1989</subfield><subfield code="e">1</subfield><subfield code="c">02</subfield><subfield code="h">16-16</subfield></datafield></record></collection>
ppnlink_with_tag_str_mv	@@773@@(DE-627)373977859
format	electronic Article
delete_txt_mv	keep
collection	springer
remote_str	true
illustrated	Not Illustrated
issn	2230-6056
topic_title	Bezafibrate has Powerful Hypolipidaemic Effects Carbohydrate Metabolism (dpeaa)DE-He213 Bezafibrate (dpeaa)DE-He213 Peripheral Insulin Sensitivity (dpeaa)DE-He213 VLDL Cholesterol (dpeaa)DE-He213 VLDL Triglyceride (dpeaa)DE-He213
topic	misc Carbohydrate Metabolism misc Bezafibrate misc Peripheral Insulin Sensitivity misc VLDL Cholesterol misc VLDL Triglyceride
spellingShingle	misc Carbohydrate Metabolism misc Bezafibrate misc Peripheral Insulin Sensitivity misc VLDL Cholesterol misc VLDL Triglyceride Bezafibrate has Powerful Hypolipidaemic Effects
topic_unstemmed	misc Carbohydrate Metabolism misc Bezafibrate misc Peripheral Insulin Sensitivity misc VLDL Cholesterol misc VLDL Triglyceride
topic_browse	misc Carbohydrate Metabolism misc Bezafibrate misc Peripheral Insulin Sensitivity misc VLDL Cholesterol misc VLDL Triglyceride
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	cr
hierarchy_parent_title	Inpharma weekly
hierarchy_parent_id	373977859
hierarchy_top_title	Inpharma weekly
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)373977859 (DE-600)2127607-9
title	Bezafibrate has Powerful Hypolipidaemic Effects
ctrlnum	(DE-627)SPR035973447 (SPR)BF03296402-e
title_full	Bezafibrate has Powerful Hypolipidaemic Effects
journal	Inpharma weekly
journalStr	Inpharma weekly
lang_code	eng
isOA_bool	false
recordtype	marc
publishDateSort	1989
contenttype_str_mv	txt
container_start_page	16
container_volume	675
format_se	Elektronische Aufsätze
doi_str_mv	10.1007/BF03296402
title_sort	bezafibrate has powerful hypolipidaemic effects
title_auth	Bezafibrate has Powerful Hypolipidaemic Effects
abstract	© Adis International Ltd 1989
abstractGer	© Adis International Ltd 1989
abstract_unstemmed	© Adis International Ltd 1989
collection_details	GBV_USEFLAG_A SYSFLAG_A GBV_SPRINGER SSG-OLC-PHA GBV_ILN_20
container_issue	1
title_short	Bezafibrate has Powerful Hypolipidaemic Effects
url	https://dx.doi.org/10.1007/BF03296402
remote_bool	true
ppnlink	373977859
mediatype_str_mv	c
isOA_txt	false
hochschulschrift_bool	false
doi_str	10.1007/BF03296402
up_date	2024-07-03T16:14:43.379Z
_version_	1803575134393466880
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">SPR035973447</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230519123207.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">201007s1989 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1007/BF03296402</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)SPR035973447</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(SPR)BF03296402-e</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Bezafibrate has Powerful Hypolipidaemic Effects</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">1989</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">© Adis International Ltd 1989</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Carbohydrate Metabolism</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Bezafibrate</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Peripheral Insulin Sensitivity</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">VLDL Cholesterol</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">VLDL Triglyceride</subfield><subfield code="7">(dpeaa)DE-He213</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Inpharma weekly</subfield><subfield code="d">Auckland : ADIS internat., 1975</subfield><subfield code="g">675(1989), 1 vom: Feb., Seite 16-16</subfield><subfield code="w">(DE-627)373977859</subfield><subfield code="w">(DE-600)2127607-9</subfield><subfield code="x">2230-6056</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:675</subfield><subfield code="g">year:1989</subfield><subfield code="g">number:1</subfield><subfield code="g">month:02</subfield><subfield code="g">pages:16-16</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://dx.doi.org/10.1007/BF03296402</subfield><subfield code="z">lizenzpflichtig</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_A</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_SPRINGER</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">675</subfield><subfield code="j">1989</subfield><subfield code="e">1</subfield><subfield code="c">02</subfield><subfield code="h">16-16</subfield></datafield></record></collection>
score	7.400055

Nicht das Richtige dabei?

Schreiben Sie uns!

Bezafibrate has Powerful Hypolipidaemic Effects

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?